PMC:7205724 / 7094-7215 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"256","span":{"begin":7,"end":16},"obj":"Species"},{"id":"257","span":{"begin":111,"end":116},"obj":"Species"}],"attributes":[{"id":"A256","pred":"tao:has_database_id","subj":"256","obj":"Tax:2697049"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T54","span":{"begin":54,"end":65},"obj":"Body_part"}],"attributes":[{"id":"A54","pred":"fma_id","subj":"T54","obj":"http://purl.org/sig/ont/fma/fma82739"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T48","span":{"begin":7,"end":11},"obj":"Disease"}],"attributes":[{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T81","span":{"begin":111,"end":116},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T104","span":{"begin":54,"end":65},"obj":"Chemical"},{"id":"T105","span":{"begin":54,"end":59},"obj":"Chemical"},{"id":"T106","span":{"begin":60,"end":65},"obj":"Chemical"}],"attributes":[{"id":"A104","pred":"chebi_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/CHEBI_33709"},{"id":"A105","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_46882"},{"id":"A106","pred":"chebi_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T73","span":{"begin":54,"end":65},"obj":"Chemical"}],"attributes":[{"id":"A73","pred":"chebi_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/CHEBI_33709"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T63","span":{"begin":7,"end":16},"obj":"Species"},{"id":"T64","span":{"begin":111,"end":116},"obj":"Species"}],"attributes":[{"id":"A63","pred":"ncbi_taxonomy_id","subj":"T63","obj":"NCBItxid:2697049"},{"id":"A64","pred":"ncbi_taxonomy_id","subj":"T64","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T65","span":{"begin":0,"end":121},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"256","span":{"begin":7,"end":16},"obj":"Species"},{"id":"257","span":{"begin":111,"end":116},"obj":"Species"}],"attributes":[{"id":"A256","pred":"pubann:denotes","subj":"256","obj":"Tax:2697049"},{"id":"A257","pred":"pubann:denotes","subj":"257","obj":"Tax:9606"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T1182","span":{"begin":0,"end":5},"obj":"CD"},{"id":"T1183","span":{"begin":7,"end":16},"obj":"NN"},{"id":"T1184","span":{"begin":17,"end":25},"obj":"NN"},{"id":"T1185","span":{"begin":26,"end":33},"obj":"NN"},{"id":"T1186","span":{"begin":34,"end":40},"obj":"NN"},{"id":"T1187","span":{"begin":41,"end":49},"obj":"VBZ"},{"id":"T1188","span":{"begin":50,"end":53},"obj":"CD"},{"id":"T1189","span":{"begin":54,"end":59},"obj":"NN"},{"id":"T1190","span":{"begin":60,"end":65},"obj":"NNS"},{"id":"T1191","span":{"begin":66,"end":75},"obj":"VBG"},{"id":"T1192","span":{"begin":76,"end":85},"obj":"JJ"},{"id":"T1193","span":{"begin":86,"end":95},"obj":"NNS"},{"id":"T1194","span":{"begin":96,"end":99},"obj":"IN"},{"id":"T1195","span":{"begin":100,"end":107},"obj":"VBG"},{"id":"T1196","span":{"begin":108,"end":110},"obj":"TO"},{"id":"T1197","span":{"begin":111,"end":116},"obj":"JJ"},{"id":"T1198","span":{"begin":117,"end":121},"obj":"NN"}],"relations":[{"id":"R1174","pred":"arg1Of","subj":"T1186","obj":"T1182"},{"id":"R1175","pred":"arg1Of","subj":"T1186","obj":"T1183"},{"id":"R1176","pred":"arg1Of","subj":"T1186","obj":"T1184"},{"id":"R1177","pred":"arg1Of","subj":"T1186","obj":"T1185"},{"id":"R1178","pred":"arg1Of","subj":"T1186","obj":"T1187"},{"id":"R1179","pred":"arg2Of","subj":"T1190","obj":"T1187"},{"id":"R1180","pred":"arg1Of","subj":"T1190","obj":"T1188"},{"id":"R1181","pred":"arg1Of","subj":"T1190","obj":"T1189"},{"id":"R1182","pred":"arg1Of","subj":"T1190","obj":"T1191"},{"id":"R1183","pred":"arg2Of","subj":"T1193","obj":"T1191"},{"id":"R1184","pred":"arg1Of","subj":"T1193","obj":"T1192"},{"id":"R1185","pred":"arg1Of","subj":"T1193","obj":"T1194"},{"id":"R1186","pred":"arg2Of","subj":"T1195","obj":"T1194"},{"id":"R1187","pred":"arg1Of","subj":"T1195","obj":"T1196"},{"id":"R1188","pred":"arg2Of","subj":"T1198","obj":"T1196"},{"id":"R1189","pred":"arg1Of","subj":"T1198","obj":"T1197"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T54","span":{"begin":54,"end":65},"obj":"Body_part"}],"attributes":[{"id":"A54","pred":"fma_id","subj":"T54","obj":"http://purl.org/sig/ont/fma/fma82739"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T47","span":{"begin":7,"end":16},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}

{"project":"LitCovid-sentences","denotations":[{"id":"T65","span":{"begin":0,"end":121},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"3.1.3 SARS-CoV2 receptor binding domain contains six amino acids providing favorable positions for binding to human ACE2"}